Tried and True ✅

This tried-and-true investment discipline always pays off. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

AN OXFORD CLUB PUBLICATION

View in browser SPONSORED America's Reckoning (Seniors Devastated) If you thought things were bad now... the worst may still be ahead. The average investor could take DECADES to recover from America's Reckoning. Don't wait to prepare... Move Your Cash Before May 5 to THIS $3 Asset (NOT Gold... Commodities... or Bonds) Editor's Note: Chief Investment Strategist Alexander Green has a knack for spotting stocks that are poised to skyrocket. And the company behind his latest finding is changing the medical landscape as we know it. Nobel Prize-winning physician Dr. Paul Ehrlich called the type of drug it specializes in a "magic bullet." The smart money is going wild over an FDA announcement... pouring money hand over fist into the one tiny company that recently gained approval... CNN Money confirms, "The smart money sees this stock as an important holding." For example, the firm that runs the Texas Teacher Retirement System - which funds the pensions of 1.6 million teachers - recently DOUBLED its holdings in this stock. Find out why it has all the makings of an ideal investment here. - Rebecca Barshop, Senior Managing Editor FINANCIAL LITERACY Most Investment Systems Won't Work... but This Will Alexander Green, Chief Investment Strategist, The Oxford Club Early in my career on Wall Street, I made an astonishing discovery: The overwhelming majority of my colleagues - bright, educated, experienced and articulate - didn't have the foggiest idea what they were talking about. This only became obvious in retrospect when I saw how their carefully constructed financial theories and investment forecasts turned to dust rather than generating any significant profits. (You'd be surprised to learn how many investment "pros" lose a substantial percentage of their own money in the market each year.) The truth is that there are limitless ways to take a beating in stocks - and only a few methods that work well over time. These few methods are codified into more widely recognized investment principles, something I try to emphasize in my columns. I was fortunate to realize this early in my career, although it still stings to think about the chunk of change I lost 35 years ago buying my own firm's "Strong Buy" recommendations. However, things finally began to turn around for me the day I read Harry Browne's Why the Best-Laid Investment Plans Usually Go Wrong - sadly, it's out of print, but you can find a few used copies on Amazon. (I loved the title, but Harry, who ran for president twice on the Libertarian ticket, told me over dinner one night that he regretted the choice. "Too negative," his publisher told him.) Browne argued that the odds are stacked against the typical investor, who is overwhelmed by Wall Street's technical jargon, market volatility and the business of money management. (Read the investment classic Where Are the Customers' Yachts? for details.) There are exceptions, of course, but the nation's brokerage firms are filled with well-dressed, smart-sounding men and women spouting a lot of self-serving nonsense. As Vanguard founder John Bogle once remarked, "It's amazing how difficult it is for a man to understand something if he's paid a small fortune not to understand it." SPONSORED DIVIDENDS: No. 1 Way to Collect Passive Income If you want to get rich, passive income is the name of the game. Real estate is risky. "Side hustles" take work. But dividend stocks are truly 100% passive! And while they might sound old-fashioned... They are the single best way to grab MORE INCOME - while you eat, sleep and vacation - month after month. Getting started couldn't be easier! To prove it, I'm giving you the Ultimate Dividend Package (FREE OF CHARGE). Click here to get it for free. The overwhelming majority of economic theories, market forecasts, trading strategies, hot tips and surefire speculations never pan out. Fortunately, we have the accumulated wisdom of history's greatest investors to guide us. I'm talking about people like Warren Buffett, Peter Lynch and John Templeton, individuals whose audited track records speak for themselves. Even though these individuals used very different approaches, they agreed that in the end there is only one thing that dictates where a stock will go: earnings. Earnings are the net profits of a business. They are what ultimately drive share prices. I challenge you to find a single company that increased its earnings quarter after quarter, year after year, and the stock didn't tag along. Conversely, try to identify a single company whose earnings declined quarter after quarter, year after year, and the stock advanced anyway. It just doesn't happen, even in a rip-roaring bull market. The reason is simple. A share of stock is not a lottery ticket. It's part ownership of a business. And just how much investors are willing to pay for those profits will determine what a company is worth in the market. Although there are always bumps along the way, you'll find there is a near-perfect correlation between a company's growth in earnings per share and the movement of its stock from quarter to quarter and year to year. So forget all the technical mumbo jumbo about market breadth, trading volume, put-call ratios, short interest, mutual fund inflows, advance/decline numbers and other market trivia. And instead remember that share prices follow earnings. Period. Stamp that on your forehead - act on it - and you'll be using the one tried-and-true investment discipline that always pays off in the end. Despite economic turbulence and volatility in the markets, there are plenty of companies in technology, e-commerce, food, pharmaceuticals, medical devices, healthcare services, defense contracting, gold mining and other recession-resistant industries that are currently making money hand over fist. Those companies are outperforming. And they're likely to keep outperforming in the weeks and months ahead. In fact, the ingenuity of the scientists at this one tiny company is lifting profits higher and curing cancer at the same time. I'll show you the road map to a potential fortune with this cancer-fighting stock. The firm is growing sales 55% year over year... Its brand-new drug, the first of its kind for ovarian cancer, was given accelerated FDA approval in November... then sold more than $2 million worth of units in just six weeks... And earlier this week, the company released promising late-stage trial data on the drug. The stock jumped 144% in a single day. But there's still plenty of room for this company to run... After all, there are four more drugs like this in the company's pipeline. Go here for the full details. Good investing, Alex Leave a Comment RECOMMENDED LINKS We've Gone From an Income Desert to an Income OASIS... Stock Legend Takes Down Biden Economy in Epic Video MORE FROM WEALTHY RETIREMENT This 6.7% Yield Isn't as Safe as It Used to Be Let It Bleed and Earn 12% per Year Expect Gold and Silver to Shoot Higher Freeport-McMoRan's Value Buoyed by Growing Copper Demand Facebook Twitter Email Share Push Alert SPONSORED "The Single Most Predictable, Profitable, Income-Gushing Investment of My 40-Year Career" - Alexander Green Thanks to a major mistake by Vladimir Putin... Wall Street is now projecting a rise from $30 to $280 for one energy stock. The company has seen profits rise 2,400% since 2020... it pays a 10% dividend... and it's now able to make up to $200 million per shipment of its product. Here's everything you need to know from legendary stock picker Alexander Green... You are receiving this email because you subscribed to Wealthy Retirement. Wealthy Retirement is published by The Oxford Club. Questions? Check out our FAQs. Trying to reach us? Contact us here. Please do not reply to this email as it goes to an unmonitored inbox. Privacy Policy | Whitelist Wealthy Retirement | Unsubscribe © 2023 The Oxford Club, LLC All Rights Reserved The Oxford Club | 105 West Monument Street | Baltimore, MD 21201 North America: 1.800.589.3430 | International: +1.443.353.4334 | Fax: 1.410.329.1923 Oxfordclub.com Nothing published by The Oxford Club should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed personalized investment advice. We allow the editors of our publications to recommend securities that they own themselves. However, our policy prohibits editors from exiting a personal trade while the recommendation to subscribers is open. In no circumstance may an editor sell a security before subscribers have a fair opportunity to exit. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication. All other employees and agents must wait 24 hours after publication before trading on a recommendation. Any investments recommended by The Oxford Club should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of The Oxford Club, LLC, 105 West Monument Street, Baltimore, MD 21201.